The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.

Por Scardino, P. T.
Publicado em 2000

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

Por Fisher, G, Yang, Z H, Kudahetti, S, Møller, H, Scardino, P, Cuzick, J, Berney, D M
Publicado em 2013

Número de ganglios linfáticos metastásicos como determinante de los resultados después de prostatectomía radical de rescate para el cáncer de próstata de radiación recurrente...

Por Gugliemetti, G, Sukhu, R, Conca Baenas, M A., Meeks, J, Sjoberg, D D., Eastham, J A., Scardino, P T., Touijer, K
Publicado no Actas Urol Esp (2016)

Long-term outcome among men with conservatively treated localised prostate cancer

Por Cuzick, J, Fisher, G, Kattan, M W, Berney, D, Oliver, T, Foster, C S, Møller, H, Reuter, V, Fearn, P, Eastham, J, Scardino, P
Publicado em 2006

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

Por Gupta, A, Roobol, M J, Savage, C J, Peltola, M, Pettersson, K, Scardino, P T, Vickers, A J, Schröder, F H, Lilja, H
Publicado em 2010

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer

Por Ahmad, I, Singh, L B, Yang, Z H, Kalna, G, Fleming, J, Fisher, G, Cooper, C, Cuzick, J, Berney, D M, Møller, H, Scardino, P, Leung, H Y
Publicado em 2013

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

Por Berney, D M, Gopalan, A, Kudahetti, S, Fisher, G, Ambroisine, L, Foster, C S, Reuter, V, Eastham, J, Moller, H, Kattan, M W, Gerald, W, Cooper, C, Scardino, P, Cuzick, J
Publicado em 2009

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

Por Cuzick, J, Berney, D M, Fisher, G, Mesher, D, Møller, H, Reid, J E, Perry, M, Park, J, Younus, A, Gutin, A, Foster, C S, Scardino, P, Lanchbury, J S, Stone, S
Publicado em 2012

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

Por Foster, C S, Dodson, A R, Ambroisine, L, Fisher, G, Møller, H, Clark, J, Attard, G, De-Bono, J, Scardino, P, Reuter, V E, Cooper, C S, Berney, D M, Cuzick, J
Publicado em 2009

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer

Por Cuzick, J, Yang, Z H, Fisher, G, Tikishvili, E, Stone, S, Lanchbury, J S, Camacho, N, Merson, S, Brewer, D, Cooper, C S, Clark, J, Berney, D M, Møller, H, Scardino, P, Sangale, Z
Publicado em 2013

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

Por Cuzick, J, Stone, S, Fisher, G, Yang, Z H, North, B V, Berney, D M, Beltran, L, Greenberg, D, Møller, H, Reid, J E, Gutin, A, Lanchbury, J S, Brawer, M, Scardino, P
Publicado no Br J Cancer (2015)

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

Por Attard, G, Clark, J, Ambroisine, L, Fisher, G, Kovacs, G, Flohr, P, Berney, D, Foster, CS, Fletcher, A, Gerald, WL, Moller, H, Reuter, V, De Bono, JS, Scardino, P, Cuzick, J, Cooper, CS
Publicado em 2007

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

Por Merson, S, Yang, Z H, Brewer, D, Olmos, D, Eichholz, A, McCarthy, F, Fisher, G, Kovacs, G, Berney, D M, Foster, C S, Møller, H, Scardino, P, Cuzick, J, Cooper, C S, Clark, J P
Publicado em 2014

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer

Por Attard, G, Clark, J, Ambroisine, L, Mills, I G, Fisher, G, Flohr, P, Reid, A, Edwards, S, Kovacs, G, Berney, D, Foster, C, Massie, C E, Fletcher, A, De Bono, J S, Scardino, P, Cuzick, J, Cooper, C S
Publicado em 2008

Anthropometric measures at multiple times throughout life and prostate cancer diagnosis, metastasis and death

Por Gerdtsson, A., Poon, B.Y., Thorek, D.L.J., Mucci, L.A., Evans, M.J., Scardino, P.T., Abrahamsson, P.A., Nilsson, P., Manjer, J., Bjartell, A., Malm, J., Vickers, A., Freedland, S.J., Lilja, H., Ulmert, D
Publicado no Eur Urol (2015)

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality

Por Sullivan, J, Kopp, R, Stratton, K, Manschreck, C, Corines, M, Rau-Murthy, R, Hayes, J, Lincon, A, Ashraf, A, Thomas, T, Schrader, K, Gallagher, D, Hamilton, R, Scher, H, Lilja, H, Scardino, P, Eastham, J, Offit, K, Vijai, J, Klein, R J
Publicado no Br J Cancer (2015)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

Por Reid, A H M, Attard, G, Ambroisine, L, Fisher, G, Kovacs, G, Brewer, D, Clark, J, Flohr, P, Edwards, S, Berney, D M, Foster, C S, Fletcher, A, Gerald, W L, Møller, H, Reuter, V E, Scardino, P T, Cuzick, J, de Bono, J S, Cooper, C S
Publicado em 2010

The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer

Por Shan, L, Ambroisine, L, Clark, J, Yáñez-Muñoz, RJ, Fisher, G, Kudahetti, SC, Yang, J, Kia, S, Mao, X, Fletcher, A, Flohr, P, Edwards, S, Attard, G, De-Bono, J, Young, BD, Foster, CS, Reuter, V, Moller, H, Oliver, TD, Berney, DM, Scardino, P, Cuzick, J, Cooper, CS, Lu, Y
Publicado em 2010